China has begun work on a facility to manufacture its first COVID-19 vaccine candidate that uses messenger RNA (mRNA) technology, even though the candidate is still in early-stage clinical trials, state-backed media reported on Monday.
Categories
China starts work on plant for mRNA-based COVID-19 vaccine candidate – media
